AnnaBelchevaMD

Hematologic Oncology

Physician

Dr. Belcheva is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
18220 State Highway 249
Ste 130
Houston, TX 77070
Phone+1 281-737-0435

Fax+1 281-737-0429

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2001 - 2004
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1998 - 2001
The University of Texas Health Science Center at San AntonioClass of 1998

PubMed

52 citations
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.
Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta
Science Translational Medicine. 2021-12-15
5 citations
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
Emre Koca, Polly A. Niravath, Joe Ensor, Tejal Patel, Xiaoxian Li
Breast Cancer Research and Treatment. 2021-04-15
18 citations
Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy.
Kartik Anand, Tejal Patel, Polly A. Niravath, Angel Rodriguez, Jorge Darcourt
Scientific Reports. 2021-01-08

8 Ways to Be There for Yourself After a Breast Cancer DiagnosisJune 23rd, 2019
NW Harris County Hospitals Offer Breast Cancer Screening, Treatment OptionsOctober 7th, 2018
Olive Oil for High Risk Breast Cancer Prevention in WomenFebruary 21st, 2014